EX-23.1 43 d680874dex231.htm EX-23.1

EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated February 27, 2018, in the Registration Statement (Form F-4) and related Proxy Statement/Prospectus of Mereo BioPharma Group plc dated January 24, 2019.

/s/ Ernst & Young LLP

Reading, United Kingdom

January 24, 2019